![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Influenza vaccination among New Zealand healthcare workers:
low rates are concerning
Lance Jennings
Influenza remains a high-profile public health issue in New
Zealand, with the seasonal influenza vaccination programme launch in March 2006,
subsequent national campaign, and the continuing focus on pandemic
preparedness.
Influenza is a serious disease. It affects New Zealanders
every winter with increased primary care consultations and hospital
admissions—some winters more than others.1,2 However, with avian influenza
A (H5N1) virus now endemic in Asia and spreading globally in poultry and
associated human infection,3 the possibility of the evolution of a virus (which
could cause another human pandemic of influenza) is real.4 Now, more than ever
before, healthcare professionals should be focusing on the national influenza
immunisation campaign.
What is the national campaign all about? The campaign
focuses on increasing awareness among public and healthcare professionals about
the seriousness of influenza, and making them aware that there is an effective
vaccine against this disease.
Those that benefit most from influenza vaccination are
individuals at greatest risk of developing complications following
influenza—the elderly, because their immune systems are on the wane;
children 6 months or older (the vaccine is not approved for children under 6
months of age who are most at risk of complications and hospital admission); and
adults with underlying medical conditions.5 These people are more likely to
develop pneumonia or other complications and be admitted to hospital or die.
The primary healthcare sector is pivotal in promoting and
administering influenza vaccine to those at risk in the community. Indeed,
research overseas and here in Canterbury clearly identifies a general
practitioner’s or practice nurse’s advocacy as being the most
important influence on a patient receiving influenza vaccine.6
If this is so, then what role do healthcare professionals in
the secondary sector have in our national programme? They have a role, as
advocates to their patients, and as advocates to their own colleagues. As
frontline doctors and nurses during the influenza season, they are in daily
close contact with patients, whom because they are in hospital, are most
vulnerable to influenza.
Annual immunisation of healthcare workers is the most
efficient way to minimise their exposure to a potentially lethal virus.7 There
is research that clearly shows that with the increasing compliance of frontline
clinical staff to having the vaccine, hospital nosocomial influenza infection
rates diminish.8 Indeed, it has been suggested that annual immunisation should
be a compulsory requirement of every healthcare worker with direct patient
contact, unless there is a specific reason otherwise.9
Additional benefits to healthcare staff from immunisation
are reduced rates of febrile illness and absenteeism during the winter influenza
season.10 Staff are also less likely to take influenza back into their families
at home.
So why are influenza vaccine uptake rates amongst hospital
staff (especially nurses) so abysmal? About 33% of all Canterbury District
Health Board (CDHB) employees received free influenza vaccine in 2004 and again
in 2005. Highest rates of uptake were amongst laboratory and administrative
staff, followed by doctors, then nurses (estimated at 16%). Surveys suggest
similar coverage rates (20–40%) are being achieved in other New Zealand
DHBs.
Anecdotal explanations for the poor response from nursing
staff (from studies carried out in Auckland, Hawke’s Bay, and Dunedin) are
varied, but largely relate to a lack of personal concern over influenza and
concern over adverse reactions to the vaccine. Such myths about influenza
vaccination clearly indicate that the major barrier is really educational.
Appropriate knowledge on the seriousness of influenza and the benefits of
influenza vaccination to themselves and their patients do not seem to be getting
through to this sector, or they are not acting on the knowledge.
Communicating the vaccination message to healthcare workers
can be approached using different strategies. These include lectures and
seminars (with support from the infection control teams) held during the
pre-winter vaccination period; messages on the hospital intranets; and displays
in meeting areas. Support of senior staff is essential.
All DHBs in New Zealand make free influenza vaccine
available to their staff, however, time constraints often make it difficult for
staff to attend vaccination clinics. Consideration of mobile vaccination clinics
to access staff who cannot leave their workplace, and “I have received
influenza vaccine” stickers may assist staff to keep working, rather than
waste time in a queue and wait for the usual observation period.
What else can be done? Targets for vaccination coverage do
not exist for healthcare settings, although a national target for 75% coverage
of those 65 years and older has been set by the Ministry of Health. Although
controversial at present, targets could be included in standards of hospital
practice and as a requirement for accreditation. Hospitals could also consider
influenza vaccination as part of the conditions of employment of staff.
With our national focus on pandemic planning, there is a
heightened awareness of the need to control seasonal outbreaks of influenza in
all settings, including the healthcare environment. The WHO recommends that all
healthcare workers who may come in contact with a patient with Highly Pathogenic
Avian Influenza, should be vaccinated with the current seasonal influenza
vaccine to lessen the possibility of a simultaneous infection and the
re-assortment of the human and avian viral genes to create a human pandemic
influenza strain. This recommendation is relevant to frontline clinical staff,
especially those in hospital acute assessment and intensive care areas.11
Influenza vaccination provides the best protection against
influenza, however the vaccine does not work unless it has been given and is in
someone’s arm. With healthcare professionals, it is more than a personal
protection issue, it is an issue of social responsibility.
Author information:
Lance C Jennings, Virologist, Canterbury Health Laboratories, Canterbury
District Health Board, Christchurch
Correspondence: Dr
Lance Jennings, Canterbury Health Laboratories, PO Box 151, Christchurch. Fax:
(03) 364 0750; email: lance.jennings@cdhb.govt.nz
References:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |